Cost effectiveness of the cancer prevention program for carriers of the BRCA1/2 mutation

OBJECTIVE: To analyze the cost effectiveness of the diagnostic program for the germline mutation in BRCA1/2 genes and of preventative strategies for the relatives of patients diagnosed with ovarian cancer associated with this mutation. METHODS: The study analyzed the cost effectiveness by developing...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramos, Marcelo Cristiano de Azevedo, Folgueira, Maria Aparecida Azevedo Koike, Maistro, Simone, Campolina, Alessandro Gonçalves, de Soárez, Patricia Coelho, de Bock, Geertruida Hendrika, Novaes, Hillegonda Maria Dutilh, Diz, Maria Del Pilar Estevez
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Faculdade de Saúde Pública da Universidade de São Paulo 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6280621/
https://www.ncbi.nlm.nih.gov/pubmed/30517521
http://dx.doi.org/10.11606/S1518-8787.2018052000643

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6280621/
https://www.ncbi.nlm.nih.gov/pubmed/30517521
http://dx.doi.org/10.11606/S1518-8787.2018052000643

Ejemplares similares